In Brief: Glaxo Wellcome
This article was originally published in The Tan Sheet
Executive Summary
Glaxo Wellcome: Glaxo Inc. President and CEO Robert Ingram appointed to the board of London-based Glaxo Wellcome plc. Ingram joined Glaxo in 1990 and was named CEO in March 1994. Prior to joining Glaxo, Ingram served as president of Merck Frosst Canada Inc. and VP-government affairs at Merck and Co. The London parent also announces the resignation of former Glaxo Chairman Charles Sanders, MD, as a director after six years on the board. Sanders had resigned from the chairman post May 1 to concentrate full-time on his U.S. Senate campaign...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning